← All candidates
Two insider buys in the last year — $1.25M in all.
102 filings on record.
CORCencora, Inc.
NYSE · Healthcare · $60.78B
$318.50
-1.48% today
Two insider buys in the last year — $1.25M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 2 buys● 13 sells◆ 10 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$60.78B
Float
180.2M
94% public
Short % float
Pro
Price / profit
24.0
Price / future profit
16.1
Price / sales
0.2
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Durcan Dermot Mark
Bought $1.10M on Jun 18 — 4,000 sh @ $274.19, held direct, 13% of their stake.
First Form 4 on file
Director
Tyler Lauren M
Bought $148.6K on Jun 22 — 550 sh @ $270.23, held direct, 13% of their stake.
No completed positions to measure
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
97 more transactions on Pro →Context
Wall St
$350.58 avg target
+10.1% vs today · 12 analysts · consensus Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
4 of 4 quarters beat
Q1 '26$4.75 act+$0.02
Q4 '25$4.08 act+$0.04
Q3 '25$3.84 act+$0.05
Q2 '25$4.00 act+$0.16
Coverage
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?Zacks · 06-18Cencora Launches Enhanced Nucleus Solution for Specialty PracticesZacks · 06-18Assessing Cencora (COR) Valuation After Kite CAR T Distribution Deal And Upcoming CFO TransitionSimply Wall St. · 06-10Cencora Kite Deal Highlights CAR T Growth And Undervalued Share Price PotentialSimply Wall St. · 06-10
The file stays open
102 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice